Citius Oncology (CTOR) Non Operating Income (2023 - 2026)

Citius Oncology's Non Operating Income history runs 4 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• In Q1 2026, Non Operating Income changed N/A year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $3.1 million (changed N/A YoY), while the FY2025 annual figure was -$181659.0, changed N/A from the prior year.
• Non Operating Income was $1.8 million for Q1 2026 at Citius Oncology, up from -$17553.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $1.8 million in Q1 2026 to a low of -$17553.0 in Q4 2025.
• Historically, Non Operating Income has averaged $757815.6 across 4 years, with a median of $758258.0 in 2024.
• Biggest YoY gain for Non Operating Income was 0.18% in 2024; the steepest drop was 21.99% in 2024.
• A 4-year view of Non Operating Income shows it stood at $579398.0 in 2023, then increased by 9.84% to $636419.0 in 2024, then sank by 102.76% to -$17553.0 in 2025, then surged by 10199.07% to $1.8 million in 2026.
• The last three Non Operating Income figures came in at $1.8 million (Q1 2026), -$17553.0 (Q4 2025), and $636419.0 (Q2 2024), per Business Quant data.